UFC’s fans are keen on personal health optimization, making the Aires tech a natural fit

• Prominent placement in UFC’s global monthly Pay Per View broadcasts
• Highlighted in custom “Defensive Strategies” segment in UFC Live Weigh-In Show
• Collaboration on original content distributed across UFC’s digital and social channels

Latest CEO Interview

Patented Healthcare Technology

Aires Resonator Neutralizes Negative Effects of EMF

• Over 20 years of R&D invested
• Proprietary silicon resonator technology is protected by a global patent pending on the entire method of protection of humans from EMF (WIPO # WO_2021064446)
• Aries Resonator creates a special EM field that restructures radiation: neutralizing negative effects of EMF and enhancing physiological performance

Product Efficacy

Aires Tech better balances power rhythms during EMF exposure

• Strong Results: Sales Quadrupled to $10M+¹ in 2023 over $2.6M in 2021 and Q4/2023 reported adj. EBITDA of $78k¹
• 2024/5: Scaling Up by Reaching Mass Market as Official Partner of UFC
• Global Patent Protects Technological Advantage
• Committed Executive Team - Owns ~23% of Shares
• Endorsed by Top Athletes & Celebrities; First OEM Deal Executed
• Successfully Commercialized: 61k customers in 93 countries

Capital Markets Profile

Exchange/Symbol

Capital Markets

• Shares Issued and Outstanding91,474,199
• Warrants & Options Outstanding42,737,734
• Fully Diluted Shares Outstanding134,211,933
• Management Ownership22%
• Market Capitalization @ C$0.57$52,140,293

Corporate Presentation